Biogen Idec - PDFSEARCH.IO - Document Search Engine

Biogen Idec
Results: 183

#	Item
51	Collaborative Search for Microorganisms in Vietnam November 2, 2005 National Institute of Technology and Evaluation Astellas Pharma Inc. Chugai Pharmaceutical Co., Ltd. Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:59:20 Chugai Pharmaceutical Co. Hoffmann-La Roche Micafungin Biogen Idec Natural product Microorganism Biology Japan Medicine Astellas Pharma Microbiology National Institute of Technology and Evaluation
52	Disclosures  Biogen Idec  Novartis  Acorda Add to Reading List Source URL: www.nmhr.org Language: English - Date: 2013-08-03 13:07:36 Autoimmune diseases Anatomy Balo concentric sclerosis Biogen Idec Lidwina Sclerosis Myelin Corinne Goldsmith Dickinson Center for Multiple Sclerosis Therapies under investigation for multiple sclerosis Multiple sclerosis Immunology Immune system
53	2014 Joint ACTRIMS-ECTRIMS Meeting EMSP Highlights Report For us at the European Multiple Sclerosis Platform (EMSP), medical congresses are one of the highlights of our calendar and this year’s joint ACTRIMS-ECTRIMS co Add to Reading List Source URL: www.emsp.org Language: English - Date: 2014-10-06 05:12:32 World Wide Web Medicine Multiple Sclerosis Trust PatientsLikeMe Multiple sclerosis Health Biogen Idec
54	2014 Joint ACTRIMS-ECTRIMS Meeting EMSP Highlights Report For us at the European Multiple Sclerosis Platform (EMSP), medical congresses are one of the highlights of our calendar and this year’s joint ACTRIMS-ECTRIMS co Add to Reading List Source URL: www.emsp.org Language: English - Date: 2014-10-06 05:10:21 World Wide Web Medicine Multiple Sclerosis Trust PatientsLikeMe Multiple sclerosis Health Biogen Idec
55	July 2014 DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-09-23 13:57:08 Immune system Multiple sclerosis Biogen Idec Natalizumab Interferon beta-1a Glatiramer acetate Fingolimod Mitoxantrone Therapies under investigation for multiple sclerosis Immunology Immunosuppressants Medicine
56	Leading the way in Multiple Sclerosis research November 5, 2014 A new Alberta-based research program aims to improve diagnosis and treatment for people with multiple sclerosis (Edmonton) Thousands of Albertans living wit Add to Reading List Source URL: eae.alberta.ca Language: English - Date: 2014-11-05 17:17:45 University of Alberta Immunosuppressants Academia Education Aaron E. Miller James L. Vincent Biogen Idec Multiple sclerosis IDEC
57	Leading the way in Multiple Sclerosis research November 5, 2014 A new Alberta-based research program aims to improve diagnosis and treatment for people with multiple sclerosis (Edmonton) Thousands of Albertans living wit Add to Reading List Source URL: www.eae.alberta.ca Language: English - Date: 2014-11-05 17:17:45 University of Alberta Immunosuppressants Academia Education Aaron E. Miller James L. Vincent Biogen Idec Multiple sclerosis IDEC
58	Betaferon II-95 Final DHPC and Communication plan including reference to Plegridy Add to Reading List Source URL: www.mhra.gov.uk Language: English - Date: 2014-10-14 07:41:24 Cytokines Kidney diseases Syndromes Autoimmune diseases Acquired hemolytic anemia Interferon beta-1a Biogen Idec Thrombotic microangiopathy Glomerulonephritis Medicine Health Anatomy
59	PDF Document Add to Reading List Source URL: www.clintonlibrary.gov Language: English - Date: 2014-06-13 22:34:40 Genentech South San Francisco California Biogen Idec Amgen Biopharmaceutical Alkermes Chiron Corporation Schering Pharmaceutical industry Pharmaceutics Technology
60	United States Court of Appeals for the Federal Circuit Miscellaneous Docket No. 901 IN RE GENENTECH, INC. and BIOGEN IDEC INC., Petitioners. Add to Reading List Source URL: www.cafc.uscourts.gov Language: English - Date: 2009-05-22 11:11:37 Biogen Idec Mandamus Law Venue Forum non conveniens

UPDATE